We are pleased to see continued progress in the Biomet hip replacement litigation. Our Firm continues to hear from Biomet M2a hip recipients who have allegedly suffered serious complications and injuries due to metal debris shed from this device.
New York, New York (PRWEB) June 13, 2013
Biomet hip lawsuit claims pending in a federal multidistrict litigation now underway in U.S. District Court, Northern District of Indiana, continue to move forward, Bernstein Liebhard LLP reports. According to an Order issued by the Court on May 5, 2013, the judge overseeing the federal Biomet hip replacement litigation has directed that depositions of Biomet employees take place in either South Bend or Fort Wayne, Indiana. According to the Order, both of these locations are significantly closer to Biomet’s Warsaw headquarters than any other venue considered by the Court. (In re: Biomet M2a Magnum Hip Implant Products Liability Litigation – MDL No. 2391)
“We are pleased to see continued progress in the Biomet hip replacement litigation. Our Firm continues to hear from Biomet M2a hip recipients who have allegedly suffered serious complications and injuries due to metal debris shed from this device,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is actively filing Biomet hip lawsuits in the federal litigation, and continues to offer free legal evaluations to individuals allegedly injured by the Biomet M2a hip.
Biomet Hip Replacement Lawsuits
All of the Biomet hip lawsuits pending in Indiana federal court allege the metal-on-metal design of the Biomet M2a Magnum can generate high levels of metal ions, leading to metallosis in the surrounding tissue and early failure of the device. According to court documents, the next Case Management Conference in the Biomet hip replacement litigation has been scheduled for June 17, 2013.
The Biomet M2a Magnum and other metal-on-metal hip implants are currently the subject of a U.S. Food & Drug Administration (FDA) safety review. In January 2013, the agency warned that metal debris shed from such devices could accumulate at dangerous levels in the tissue surrounding the hip implant, as well as the blood stream. According to the FDA, this could lead to pain, swelling, metallosis, premature failure of the hip, and possibly even systemic reactions in other parts of the body. The FDA has advised that patients with all-metal hips undergo blood testing for elevated metal ion levels if they show signs of a failing hip implant. The FDA has also proposed a new rule which would preclude metal-on-metal hips from the agency’s 510 (k) clearance process, which allowed devices like the Biomet M2a Magnum to come to market without first undergoing human clinical trials.*
Alleged victims of metal-on-metal hip implant failure associated with the Biomet M2a hip may be entitled to compensation for medical bills, lost wages, and pain and suffering. A wealth of information about Biomet hip lawsuits is available at Bernstein Liebhard’s website. For additional information, please contact one of our attorneys today by calling 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for
this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP